Mastering Uterine Cancer Staging: Essential ESUR Guidelines

Uterine malignancies present significant clinical challenges for gynecologists and oncologists in India. Consequently, accurate uterine cancer MRI staging plays a crucial role in optimizing treatment strategies. Indeed, magnetic resonance imaging offers unparalleled soft tissue contrast, which helps clinicians delineate local tumor spread. Therefore, we outline the latest practice recommendations from the European Society of Urogenital Radiology (ESUR) in this clinical guide.

Standardizing Uterine Cancer MRI Staging Protocols

In addition, clinical centers must adhere to standardized imaging guidelines to achieve high-quality images. Specifically, ESUR recommends utilizing multiparametric MRI protocols. These protocols always include high-resolution T2-weighted imaging to evaluate the normal uterine anatomy. Additionally, diffusion-weighted imaging (DWI) provides excellent tumor-to-myometrium contrast, which assists in identifying tumor margins. Radiologists should also perform dynamic contrast-enhanced (DCE) sequences in selected cases. However, patients must prepare properly before the examination. For instance, maintaining a moderately full bladder helps displace bowel loops away from the uterus. Furthermore, administering anti-peristaltic agents reduces motion artifacts, which significantly improves overall image quality.

Clinical Indications and Patient Selection

MRI serves as the preferred imaging modality for several key clinical indications. First, doctors utilize MRI to stage endometrial and cervical cancers. Second, the modality helps assess patient eligibility for fertility-preserving treatments. In young patients, preserving fertility remains a critical priority. Consequently, MRI must accurately confirm the absence of deep myometrial or parametrial invasion. Third, clinicians use MRI to characterize indeterminate myometrial lesions. Although benign leiomyomas are common, radiologists must confidently exclude uterine sarcomas. Since leiomyosarcoma is the most common sarcoma subtype, distinguishing it from benign mimics is vital. Thus, multiparametric sequences provide the necessary specificity for these challenging cases.

Complementary Role of FDG-PET and CT

While MRI excels at local staging, systemic evaluation requires complementary imaging modalities. For example, clinicians routinely utilize computed tomography (CT) for distant metastasis staging. Specifically, chest and abdominal CT scans help detect pulmonary and peritoneal spread. On the other hand, 18-fluorodeoxyglucose positron emission tomography (FDG-PET) complements MRI in cervical cancer cases. Indeed, FDG-PET offers the highest diagnostic accuracy for detecting pelvic lymph node and distant metastases. This imaging combination therefore ensures complete systemic evaluation. Consequently, oncologists can confidently tailor treatment strategies, avoiding unnecessary surgical procedures for advanced disease.

Structuring the Radiology Report

A complete and clinically relevant radiology report must follow established guidelines. To achieve this, radiologists should use structured templates. Structured reporting reduces variability and ensures that clinicians receive all critical staging parameters. For instance, the report must clearly describe the tumor size and the depth of myometrial invasion. Furthermore, it should document cervical stromal involvement and vaginal extension. Radiologists must also assess the parametria and evaluate regional lymph nodes. Ultimately, high-quality, standardized reporting directly translates to improved patient outcomes and more consistent clinical trials.

Frequently Asked Questions

Q1: Why is MRI the preferred modality for uterine cancer staging?

MRI offers superior soft tissue contrast and multiplanar imaging capabilities. Therefore, it allows radiologists to assess the depth of myometrial invasion and cervical stromal involvement with high accuracy.

Q2: How should a patient prepare before undergoing a uterine pelvic MRI?

First, patients should maintain a moderately full bladder to push bowel loops away from the uterus. Additionally, clinical staff should administer anti-peristaltic agents to minimize motion artifacts and secure high-quality images.

Q3: What role does FDG-PET play in cervical cancer evaluation?

While MRI excels at local staging, FDG-PET complements it by identifying pelvic lymph node and distant metastases. Consequently, this helps oncologists plan systemic therapy or extended-field radiation.

References

1. Ninkova RV et al. ESR Essentials: uterine cancers-practice recommendations by the European Society of Urogenital Radiology. Eur Radiol. 2026 Jul 01. doi: 10.1007/s00330-026-12705-2. PMID: 42380325.
2. Nougaret S et al. Endometrial Cancer MRI staging: Updated Guidelines of the European Society of Urogenital Radiology. Eur Radiol. 2019 Feb;29(2):792-805. doi: 10.1007/s00330-018-5515-y.
3. Manganaro L et al. Staging, recurrence and follow-up of uterine cervical cancer using MRI: Updated Guidelines of the European Society of Urogenital Radiology after revised FIGO staging 2018. Eur Radiol. 2021 Nov;31(11):7802-7816. doi: 10.1007/s00330-021-08144-x.